
Please find enclosed press release titled "Fredun Pharmaceuticals Reports 61% YoY Growth in EBITDA to 39.33 Cr in H1 FY26" issued by Fredun Pharmaceutcals Limited.
Filed with BSE ·

Please find enclosed press release titled "Fredun Pharmaceuticals Reports 61% YoY Growth in EBITDA to 39.33 Cr in H1 FY26" issued by Fredun Pharmaceutcals Limited.
6ix hasn’t read this filing yet.
Fredun Pharmaceuticals Ltd. on 6ix
Follow Fredun Pharmaceuticals into a list and get an email when it puts out news.
Follow Fredun Pharmaceuticals